South Africa is looking for 300 participants to take part in a first-ever cannabis trial that will examine the plant’s potential as an effective alternative treatment for chronic pain among patients currently using opioids. Results of this year-long study being undertaken by the Cannabis Research Institute of South Africa (CRI) are expected in late 2023, reported Business Insider. 

South Africa showed an openness to marijuana in 2018 when the Constitutional Court decriminalized personal use. Four years later, however, the South African Health Products Regulatory Authority (SAHPRA) has yet to officially approve marijuana-based medicine for pain relief. 

Trial Details 

The trial, in partnership with Releaf Cannabis E-Clinics, will provide participants with medical marijuana throughout the study and will make certain that participants “stay on the medication until weaning off opioids becomes possible." Volunteers will be obliged to fill out questionnaires every month prior to receiving their next prescription. 

To become a participant in the study, people need to prove they suffer from chronic pain. Usually, these patients have illnesses like multiple sclerosis, rheumatoid arthritis, osteoarthritis and cancer-related conditions, among others. 

Finding Alternative For Opioids 

Among the most common pain medications are opioids, such as morphine, fentanyl, and tramadol, which …

Full story available on Benzinga.com